Peixue Li

1.6k total citations · 1 hit paper
17 papers, 1.2k citations indexed

About

Peixue Li is a scholar working on Molecular Biology, Cell Biology and Computer Networks and Communications. According to data from OpenAlex, Peixue Li has authored 17 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 9 papers in Cell Biology and 2 papers in Computer Networks and Communications. Recurrent topics in Peixue Li's work include Hippo pathway signaling and YAP/TAZ (9 papers), Wnt/β-catenin signaling in development and cancer (3 papers) and Network Security and Intrusion Detection (2 papers). Peixue Li is often cited by papers focused on Hippo pathway signaling and YAP/TAZ (9 papers), Wnt/β-catenin signaling in development and cancer (3 papers) and Network Security and Intrusion Detection (2 papers). Peixue Li collaborates with scholars based in China, United States and Canada. Peixue Li's co-authors include Hongbin Ji, Zhaocai Zhou, Tong Guo, Zhubing Shi, Yun Zhao, Huizhen Wang, Lei Zhang, Zhenzhen Zhang, Feng He and Xin Wang and has published in prestigious journals such as Nature Communications, Blood and PLoS ONE.

In The Last Decade

Peixue Li

17 papers receiving 1.2k citations

Hit Papers

A Peptide Mimicking VGLL4 Function Acts as a YAP Antagoni... 2014 2026 2018 2022 2014 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peixue Li China 12 801 640 113 95 84 17 1.2k
Manuel A. Fernández Spain 8 366 0.5× 470 0.7× 25 0.2× 43 0.5× 58 0.7× 10 855
Ming Shao China 19 138 0.2× 602 0.9× 83 0.7× 24 0.3× 143 1.7× 67 1.2k
Tongli Zhang United States 16 351 0.4× 692 1.1× 236 2.1× 71 0.7× 68 0.8× 43 1.0k
Yanping Wu China 11 215 0.3× 228 0.4× 59 0.5× 11 0.1× 106 1.3× 34 523
Paola Merlo United States 12 219 0.3× 739 1.2× 340 3.0× 49 0.5× 90 1.1× 16 1.2k
Satoshi Okawa Japan 17 43 0.1× 811 1.3× 55 0.5× 72 0.8× 102 1.2× 67 1.2k
Yongbo Wang China 20 46 0.1× 817 1.3× 108 1.0× 192 2.0× 214 2.5× 53 1.2k
Ariel Jaimovich United States 12 106 0.1× 447 0.7× 156 1.4× 27 0.3× 93 1.1× 30 631
David Schubert United States 11 139 0.2× 507 0.8× 23 0.2× 60 0.6× 38 0.5× 18 760
Weizhong Liu China 15 140 0.2× 302 0.5× 24 0.2× 348 3.7× 24 0.3× 63 841

Countries citing papers authored by Peixue Li

Since Specialization
Citations

This map shows the geographic impact of Peixue Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peixue Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peixue Li more than expected).

Fields of papers citing papers by Peixue Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peixue Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peixue Li. The network helps show where Peixue Li may publish in the future.

Co-authorship network of co-authors of Peixue Li

This figure shows the co-authorship network connecting the top 25 collaborators of Peixue Li. A scholar is included among the top collaborators of Peixue Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peixue Li. Peixue Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Li, Peixue, Qing Su, Lijie Wang, et al.. (2023). Multiplex Genome Editing of Human T Cells with Innovative Transformer Base Editor (tBE) for Construction of Next Generation CAR-T Therapies. Blood. 142(Supplement 1). 6825–6825. 1 indexed citations
2.
Zhang, Liao, et al.. (2020). Omni SCADA Intrusion Detection Using Deep Learning Algorithms. IEEE Internet of Things Journal. 8(2). 951–961. 71 indexed citations
3.
Xu, Liang, Peixue Li, Hao Xue, et al.. (2020). SHANK2 is a frequently amplified oncogene with evolutionarily conserved roles in regulating Hippo signaling. Protein & Cell. 12(3). 174–193. 14 indexed citations
4.
Zhang, Liao, et al.. (2019). LSTM for SCADA Intrusion Detection. GoeScholar The Publication Server of the Georg-August-Universität Göttingen (Georg-August-Universität Göttingen). 1–5. 11 indexed citations
5.
Huang, Hsin‐Yi, Wenjing Zhang, Yijun Gao, et al.. (2017). YAP Suppresses Lung Squamous Cell Carcinoma Progression via Deregulation of the DNp63–GPX2 Axis and ROS Accumulation. Cancer Research. 77(21). 5769–5781. 68 indexed citations
6.
Zhu, Baoqing, Jun Niu, Peixue Li, et al.. (2016). Volatile Constituents from the Fruits ofLindera glauca(Sieb. et Zucc.) with Different Maturities. Journal of Essential Oil Bearing Plants. 19(4). 926–935. 10 indexed citations
7.
Jiang, Fangfang, Falong Lu, Peixue Li, et al.. (2015). Drosophila Homolog of FMRP Maintains Genome Integrity by Interacting with Piwi. Journal of genetics and genomics. 43(1). 11–24. 14 indexed citations
8.
Wang, Chao, Wenxiang Zhang, Meng-Xin Yin, et al.. (2015). Suppressor of Deltex mediates Pez degradation and modulates Drosophila midgut homeostasis. Nature Communications. 6(1). 6607–6607. 16 indexed citations
9.
Dong, Liang, Jinhui Li, Hongling Huang, et al.. (2015). Growth suppressor lingerer regulatesbantammicroRNA to restrict organ size. Journal of Molecular Cell Biology. 7(5). 415–428. 10 indexed citations
10.
Jiao, Shi, Huizhen Wang, Zhubing Shi, et al.. (2014). A Peptide Mimicking VGLL4 Function Acts as a YAP Antagonist Therapy against Gastric Cancer. Cancer Cell. 25(2). 166–180. 505 indexed citations breakdown →
11.
Wang, Huizhen, Zhubing Shi, Aimei Dong, et al.. (2014). A Peptide Mimicking VGLL4 Function Acts as a YAP Antagonist Therapy against Gastric Cancer. Cancer Cell. 25(3). 406–406. 7 indexed citations
12.
Niu, Jun, Baoqing Zhu, Jian Cai, et al.. (2014). Selection of Reference Genes for Gene Expression Studies in Siberian Apricot (Prunus sibirica L.) Germplasm Using Quantitative Real-Time PCR. PLoS ONE. 9(8). e103900–e103900. 28 indexed citations
13.
Zhang, Wenjing, Yijun Gao, Peixue Li, et al.. (2014). VGLL4 functions as a new tumor suppressor in lung cancer by negatively regulating the YAP-TEAD transcriptional complex. Cell Research. 24(3). 331–343. 246 indexed citations
14.
Guo, Tong, Yi Lu, Peixue Li, et al.. (2013). A novel partner of Scalloped regulates Hippo signaling via antagonizing Scalloped-Yorkie activity. Cell Research. 23(10). 1201–1214. 92 indexed citations
15.
Yan, Junhua, et al.. (2013). Responses of CO2, N2O and CH4 fluxes between atmosphere and forest soil to changes in multiple environmental conditions. Global Change Biology. 20(1). 300–312. 39 indexed citations
16.
Jin, Yunyun, Jinjin Xu, Meng-Xin Yin, et al.. (2013). Brahma is essential for Drosophila intestinal stem cell proliferation and regulated by Hippo signaling. eLife. 2. e00999–e00999. 56 indexed citations
17.
Zheng, Yunpu, Qingpeng Yang, Ming Xu, et al.. (2012). Responses ofPinus massonianaandPinus taedato freezing in temperate forests in central China. Scandinavian Journal of Forest Research. 27(6). 520–531. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026